| Dewing Medicine Inc | |
|
31862 Coast Hwy Ste 200 Laguna Beach CA 92651-6771 | |
| (949) 340-5454 | |
| (949) 340-5454 |
| Full Name | Dewing Medicine Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 31862 Coast Hwy Ste 200, Laguna Beach, California |
| Authorized Official Name and Position | Janne Huynh Dewing (PRESIDENT) |
| Authorized Official Contact | 9493405454 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Dewing Medicine Inc 31862 Coast Hwy Ste 200 Laguna Beach CA 92651-6771 Ph: (949) 340-5454 | Dewing Medicine Inc 31862 Coast Hwy Ste 200 Laguna Beach CA 92651-6771 Ph: (949) 340-5454 |
| NPI Number | 1215180088 |
|---|---|
| Provider Enumeration Date | 10/24/2008 |
| Last Update Date | 01/05/2024 |
| Medicare PECOS PAC ID | 8921156928 |
|---|---|
| Medicare Enrollment ID | O20090430000546 |
News Archive
University of Texas Medical Branch researchers have uncovered an association between free radical-mediated reactions and the severity and progression of system lupus erythematosus. Higher levels of oxidative and nitrosative stress markers were found in SLE patients with greater disease activity suggesting a causal relationship. Full findings of the study are available in the July issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
Champions Oncology today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft PDX models) in patients with metastatic or recurrent sarcoma. Mount Sinai Hospital in Toronto, Canada is the first clinical site to enroll patients in the newly-opened study.
New Leaf Venture Partners (NLV Partners) announced today the closing of the second tranche of a $26 million investment in Oxford Immunotec Ltd., a leading manufacturer and marketer of T cell-based diagnostic tests. The Series D financing was led by NLV Partners, and additional participants included new investor Kaiser Permanente Ventures and existing investors Clarus Ventures, Wellington Partners, Kuwait-based National Technology Enterprises Company, SPARK Ventures, DFJ Esprit, Oxford University and The Dow Chemical Company.
Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to predict a patient's response to therapy.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215180088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | C52349 (California) | Primary |
| Provider Name | Janne Dewing |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699973297 PECOS PAC ID: 3476601477 Enrollment ID: I20090430000542 |
News Archive
University of Texas Medical Branch researchers have uncovered an association between free radical-mediated reactions and the severity and progression of system lupus erythematosus. Higher levels of oxidative and nitrosative stress markers were found in SLE patients with greater disease activity suggesting a causal relationship. Full findings of the study are available in the July issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
Champions Oncology today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft PDX models) in patients with metastatic or recurrent sarcoma. Mount Sinai Hospital in Toronto, Canada is the first clinical site to enroll patients in the newly-opened study.
New Leaf Venture Partners (NLV Partners) announced today the closing of the second tranche of a $26 million investment in Oxford Immunotec Ltd., a leading manufacturer and marketer of T cell-based diagnostic tests. The Series D financing was led by NLV Partners, and additional participants included new investor Kaiser Permanente Ventures and existing investors Clarus Ventures, Wellington Partners, Kuwait-based National Technology Enterprises Company, SPARK Ventures, DFJ Esprit, Oxford University and The Dow Chemical Company.
Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to predict a patient's response to therapy.
› Verified 2 days ago
News Archive
University of Texas Medical Branch researchers have uncovered an association between free radical-mediated reactions and the severity and progression of system lupus erythematosus. Higher levels of oxidative and nitrosative stress markers were found in SLE patients with greater disease activity suggesting a causal relationship. Full findings of the study are available in the July issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
Champions Oncology today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft PDX models) in patients with metastatic or recurrent sarcoma. Mount Sinai Hospital in Toronto, Canada is the first clinical site to enroll patients in the newly-opened study.
New Leaf Venture Partners (NLV Partners) announced today the closing of the second tranche of a $26 million investment in Oxford Immunotec Ltd., a leading manufacturer and marketer of T cell-based diagnostic tests. The Series D financing was led by NLV Partners, and additional participants included new investor Kaiser Permanente Ventures and existing investors Clarus Ventures, Wellington Partners, Kuwait-based National Technology Enterprises Company, SPARK Ventures, DFJ Esprit, Oxford University and The Dow Chemical Company.
Recent advances in the understanding of cancer have led to more personalized therapies, such as drugs that target particular proteins and tests that analyze gene expression patterns in tumors to predict a patient's response to therapy.
› Verified 2 days ago
Cam Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1968 S Coast Hwy # 401, Laguna Beach, CA 92651 Phone: 801-508-4155 | |
Gabrielle Thompson Wy Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1968 S Coast Hwy # 634, Laguna Beach, CA 92651 Phone: 619-780-4839 | |
Laguna Beach Community Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 362 3rd St, Laguna Beach, CA 92651 Phone: 949-494-0761 Fax: 949-494-3154 | |
Laguna Eyes Optometry Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1100 S Coast Hwy, Ste 201, Laguna Beach, CA 92651 Phone: 949-497-1769 Fax: 949-497-2808 | |
C Hinchliffe Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 31852 Coast Hwy, 400, Laguna Beach, CA 92651 Phone: 949-499-2707 Fax: 949-499-2067 | |
Gail T. Schoenau, M.d., Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 31862 Coast Hwy, Suite 204, Laguna Beach, CA 92651 Phone: 949-499-8233 Fax: 949-499-8238 |